Lifitegrast Mechanism of Action
Laura Periman, MD, describes the mechanism of action of lifitegrast for the treatment of dry eye disease.
Stay updated with breaking news from Ocular Surface. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Laura Periman, MD, describes the mechanism of action of lifitegrast for the treatment of dry eye disease.
Brandon Ayres, MD, provides an overview of lifitegrast efficacy and safety from the OPUS trials for the treatment of dry eye disease.
/PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their new global Workshop...
Experts provide an overview of the diagnostic process for identifying dry eye disease.
Experts discuss diagnosing meibomian gland dysfunction (MGD), the most common cause of dry eye disease.